Edition:
United States

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

2.75USD
16 Aug 2018
Change (% chg)

-- (--)
Prev Close
$2.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
169,946
52-wk High
$19.30
52-wk Low
$2.65

Chart for

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.39
Market Cap(Mil.): $102.71
Shares Outstanding(Mil.): 37.21
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 95.67 30.17
EPS (TTM): -2.02 -- --
ROI: -57.85 3.33 12.67
ROE: -61.47 2.31 14.86

BRIEF-Newlink Genetics Corp Reports Qtrly Loss Per Share Of $0.49

* NEWLINK GENETICS CORP QTRLY BASIC AND DILUTED LOSS PER SHARE $0.49

May 03 2018

BRIEF-Newlink Genetics Appoints Matthew Sherman To Board

* NEWLINK GENETICS - IN CONNECTION WITH APPOINTMENT OF MATTHEW SHERMAN TO CO'S BOARD, BOARD WILL BE COMPRISED OF EIGHT DIRECTORS Source text for Eikon: Further company coverage:

May 01 2018

BRIEF-Newlink Genetics Reviews Clinical Programs

* IN LIGHT OF INCYTE'S ANNOUNCEMENT REGARDING ECHO-301 TRIAL, CO UNDERTAKING REVIEW OF CLINICAL PROGRAMS Source text for Eikon: Further company coverage:

Apr 06 2018

BRIEF-NewLink Genetics, Cantor Fitzgerald Enter Controlled Equity Offering Sales Agreement

* NEWLINK GENETICS SAYS ON MARCH 12, CO ENTERED CONTROLLED EQUITY OFFERING(SM)SALES AGREEMENT WITH CANTOR FITZGERALD & CO - SEC FILING

Mar 13 2018

BRIEF-NewLink Genetics Qtrly Loss Per Share $0.37

* NEWLINK GENETICS REPORTS FOURTH QUARTER, YEAR-END 2017 FINANCIAL RESULTS AND PROVIDES UPDATE FOR INDOXIMOD PROGRAMS

Mar 01 2018

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,882 +25.00
Pfizer Inc. (PFE.N) $41.42 --
Novartis AG (NOVN.S) CHF82.52 +0.80
Merck & Co., Inc. (MRK.N) $68.85 --
Roche Holding Ltd. (ROG.S) CHF240.10 +0.90
Roche Holding Ltd. (RO.S) CHF243.40 +0.40
Abbott Laboratories (ABT.N) $64.16 --
Sanofi SA (SASY.PA) €73.10 +0.44
AstraZeneca plc (AZN.L) 5,928.00 -8.00
GlaxoSmithKline plc (GSK.L) 1,612.20 +2.20

Earnings vs. Estimates